Top 10 Hospital GPOs Shaping US Pharmacy Access 2026
Vizient and Premier alone represent over 60% of US hospital beds — here’s the full GPO landscape shaping formulary and
Read More
Pharmacta
Industry Intelligence
Latest:
- The GLP-1 Access Paradox: Policy Wins, But 48 Million Americans Still Can’t Afford Them
- The Hospital Pharmacy Visibility Crisis: 80% Lack Real-Time Supply Chain Insight
- BioNTech’s mRNA Cancer Vaccine Failure: What Colorectal Cancer Teaches About Immunotherapy’s Limits
- Takeda Just Broke a 40-Year Treatment Drought for Rare Blood Cancer—And It’s About to Transform Patient Lives
- FDA Just Approved Mounjaro for Heart Protection—Here’s Why This Changes Diabetes Treatment Forever
Top 10 Pharma Serialization & Track-and-Trace Vendors 2026
Small dispensers hit their final DSCSA deadline November 27, 2026 — here are the ten serialization vendors that can get
Read More
Top 10 Pharma 3PL & Distribution Providers 2026 Ranked
The pharma 3PL market hits $73 billion in 2026 — here are the ten distribution partners with the warehousing scale
Read More
Top 10 Pharmacy Benefit Managers Shaping US Access 2026
Three companies process 80% of all US prescription claims — here’s the full PBM and market access landscape hospital pharmacy
Read More
Top 10 Pharma Cold Chain Logistics Providers 2026
The global pharma cold chain market is racing to $48.76B by 2035 — here are the ten logistics providers that
Read More
Top 10 India Pharma Manufacturers CDMOs 2026
With 350+ USFDA-registered facilities and 30-40% lower costs, these are the Indian CDMOs capturing China+1 diversification demand in 2026. India
Read More
Top 10 UK & EU Pharma Manufacturers CDMOs 2026
With 74% of Europe’s APIs still sourced from Asia, these are the UK and EU CDMOs positioned to capture reshoring
Read More
Top 10 US Pharma Manufacturers CDMOs Ranked 2026
The US CDMO market is racing past $39 billion as sponsors reshore from China — here’s who actually has the
Read More